US states sue OxyContin maker over opioid crisis

May 16, 2018

Six US states sued OxyContin maker Purdue Pharma on Tuesday for alleged deceptive trade practices related to its marketing of the opioid painkiller.

The coordinated but separately filed lawsuits were part of a wave of similar actions taken by and municipalities throughout the United States in connection with an drug abuse crisis that costs thousands of lives a year and has increased heroin addiction.

"My office is holding Purdue Pharma accountable for fueling the nation's opioid epidemic by deceptively marketing including OxyContin when it knew their drugs were potentially dangerous," Texas Attorney General Ken Paxton said.

Attorneys general of five other states—Nevada, Florida, North Carolina, North Dakota and Tennessee—also filed lawsuits against Purdue Pharma on Tuesday.

Florida sued additional companies, including Endo Pharmaceuticals and several drug distributors.

A bipartisan group of 41 state attorneys general also is conducting an investigation into whether opioid drug manufacturers and distributors broke the law.

In October, President Donald Trump described the opioid crisis as a national public health emergency. An estimated 2.4 million Americans are addicted to narcotics including prescription painkillers and heroin.

There were more than 42,000 opioid overdoses nationwide in 2016, and a death toll that has quadrupled over the last two decades, according to the Centers for Disease Control.

Pop icon Prince and rocker Tom Petty are among the most high profile victims.

Purdue Pharma said in February that it had told its salespeople to no longer encourage doctors to prescribe anti-pain medications such as OxyContin.

The company did not immediately respond to a request for comment.

Explore further: 6 US states accuse opioid maker Purdue of fueling overdoses

Related Stories

6 US states accuse opioid maker Purdue of fueling overdoses

May 15, 2018
Six U.S. states on Tuesday sued the maker of the opioid OxyContin of using deceptive marketing to boost drug sales that fueled opioid overdose deaths.

Alabama files lawsuit against opioid manufacturer

February 6, 2018
Alabama on Tuesday filed a lawsuit against the manufacturer of OxyContin and other opioids, becoming the latest state seeking to hold drug companies accountable for an addiction epidemic.

Opioid maker changes tack as scrutiny mounts

February 14, 2018
Accused of profiting from a deadly opioid crisis ravaging middle class America, the maker of the world's best-selling pain medication, Purdue Pharma, said Tuesday it is changing tack in the face of increasing scrutiny.

Study links rising heroin deaths to 2010 OxyContin reformulation

April 9, 2018
Efforts by Purdue Pharma in 2010 to make its blockbuster prescription opioid painkiller OxyContin less prone to abuse did nothing to reduce the number of drug overdose deaths across the nation. In fact, according to researchers ...

Ohio sues five drugmakers over role in opioid crisis

May 31, 2017
The US state of Ohio on Wednesday sued five major producers of prescription opioid medications, accusing them of lying about the deadly risks the painkillers—at the center of a nationwide addiction crisis—posed to public ...

New York hits big pharma with $500mn lawsuit in opioid crisis

January 23, 2018
New York turned the screws on pharmaceutical giants in America's opioid epidemic, suing manufacturers for $500 million on Tuesday as a photographer kickstarted a petition to hold Purdue Pharma accountable as a recovering ...

Recommended for you

Novel botulinum toxin compound relieves chronic pain

July 18, 2018
A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to research by UCL, ...

FDA recalls heart medication valsartan, citing cancer concerns

July 17, 2018
The U.S. Food and Drug Administration issued a voluntary recall of several medications that contain the active ingredient valsartan, which is used to treat high blood pressure and heart failure.

Opioids given too easily to children: study

July 16, 2018
(HealthDay)—Many children are prescribed powerful opioid painkillers they don't really need, putting them and those around them at risk, a new study shows.

Study reveals opioid patients face multiple barriers to treatment

July 12, 2018
In areas of the country disproportionately affected by the opioid crisis, treatment programs are less likely to accept patients paying through insurance of any type or accept pregnant women, a new Vanderbilt study found.

Report details possible conflict of interest issues for FDA advisors

July 6, 2018
Charles Piller, a contributing correspondent for the journal Science, has published a Feature piece in the journal detailing what he describes as possible conflicts of interest issues by people who serve as advisors to the ...

Opioid epidemic responses overlook gender

July 5, 2018
Yale health experts warn that current efforts to confront the growth of opioid addiction and overdose deaths must better incorporate an understanding of how women fit into this epidemic.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.